CEL-SCI Corporation announced new data has been published from its prior Phase 3 study of Multikine* (Leukocyte Interleukin, Injection) in newly diagnosed, treatment naïve, resectable, locally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback